The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Impaired Endothelial Function in Young Women with Premature Ovarian Failure: Normalization with Hormone Therapy
Abstract
Normal menopause is associated with vascular endothelial dysfunction, an early stage of atherosclerosis. The effect of premature ovarian failure (or premature menopause) on endothelial function in young women is unknown. Endothelial function was assessed in 18 women with premature ovarian failure before and after 6 months of hormone therapy and was compared with the endothelial function of 20 age- and body mass index-matched premenopausal women. Brachial artery diameter was measured both during hyperemia (an index of endothelium-dependent vasodilation) and in response to glyceryl trinitrate (an index of endothelium-independent vaso-dilation). Flow-mediated dilation was significantly lower in women with premature ovarian failure at baseline (increase in brachial artery diameter during hyperemia by 3.06 +/- 4.33%) than in control women (increase by 8.84 +/- 2.15%; P < 0.0005). Glyceryl trinitrate-induced vasodilation did not differ between the groups. After hormone therapy for 6 months, flow-mediated dilation was improved in women with premature ovarian failure, increasing by more than 2-fold (7.41 +/- 3.86%; P < 0.005 compared with pretreatment) and reaching normal values (P not significant compared with control women). Glyceryl trinitrate-induced vasodilation did not change after treatment in women with premature ovarian failure. Young women with premature ovarian failure have significant vascular endothelial dysfunction. Early onset of endothelial dysfunction associated with sex steroid deficiency may contribute to the increased risk of cardiovascular disease and mortality in young women with premature ovarian failure. Hormone therapy restores endothelial function within 6 months of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial dysfunction, which has been found in women with premature menopause and in those with adverse pregnancy outcomes, might trigger pregnancy complications and remain beyond these complications to predispose women to future cardiovascular disease”
From Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review (2020) · cites this paper as [147]
Citations
Cites
1 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520
RetractedFriedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I., Sullivan, I. D., Lloyd, J. K., & Deanfield, J. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)93147-f · Cited by 4,742
Corretti, M. C., Anderson, T. J., Benjamin, E. J., Celermajer, D. S., Charbonneau, F., Creager, M. A., Deanfield, J. E., Drexler, H., Gerhard‐Herman, M. D., Herrington, D. M., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01746-6 · Cited by 4,606
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,589
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
Close Relation of Endothelial Function in the Human Coronary and Peripheral Circulations
Anderson, T. J., Uehata, A., Gerhard, M. D., Meredith, I. T., Knab, S., Delagrange, D., Lieberman, E. H., Ganz, P., Creager, M. A., Yeung, A. C., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00327-4 · Cited by 2,033
Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
Grodstein, F., Stampfer, M. J., Manson, J. E., Colditz, G. A., Willett, W. C., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350701 · Cited by 1,294
Menopause and the Risk of Coronary Heart Disease in Women
Colditz, G. A., Willett, W. C., Stampfer, M. J., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704303161801 · Cited by 1,153
Walsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., & Sacks, F. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251702 · Cited by 1,152
Incidence of Premature Ovarian Failure
Coulam, C. B., Adamson, S. C., & Annegers, J. F. (1987) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198703000-00020 · Cited by 1,024
Goswami, D., & Conway, G. S. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi012 · Cited by 713
Estrogen in the Prevention of Atherosclerosis
Hodis, H. N., Mack, W. J., Lobo, R. A., Shoupe, D., Sevanian, A., Mahrer, P. R., Selzer, R. H., Liu, C., Ci-hua, L., & Azen, S. P. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00005 · Cited by 691
Age at menopause as a risk factor for cardiovascular mortality
van der Schouw, Y. T., van der Graaf, Y., Steyerberg, E. W., Eijkemans, M. J. C., & Banga, J. D. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90075-6 · Cited by 616
Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women
Sack, M. N., Rader, D. J., & Cannon, R. O. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91117-7 · Cited by 525
Post, W. S. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00153-4 · Cited by 481
Age at Natural Menopause and Risk of Cardiovascular Disease
Hu, F. B., Grodstein, F., Hennekens, C. H., Colditz, G. A., Johnson, M., Manson, J. E., ROSNER, B. A., & Stampfer, M. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1061 · Cited by 414
Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women
Hodis, H. N., Mack, W. J., Azen, S. P., Lobo, R. A., Shoupe, D., Mahrer, P. R., Faxon, D. P., Cashin-Hemphill, L., Sanmarco, M. E., French, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030830 · Cited by 386
Is early natural menopause a biologic marker of health and aging?
Snowdon, D. A., Kane, R. L., Beeson, W. L., Burke, G. L., Sprafka, J. M., Potter, J. D., Iso, H., Jacobs, D. R., & Phillips, R. L. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.6.709 · Cited by 342
Understanding the Divergent Data on Postmenopausal Hormone Therapy
Grodstein, F., Clarkson, T. B., & Manson, J. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmsb022365 · Cited by 325
Merz, C. N. B., Johnson, B. D., Sharaf, B. L., Bittner, V., Berga, S. L., Braunstein, G. D., Hodgson, T. K., Matthews, K. A., Pepine, C. J., Reís, S. E., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02763-8 · Cited by 287
Age at Natural Menopause and Mortality
Cooper, G. S., & Sandler, D. P. (1998) · Annals of Epidemiology · doi:10.1016/s1047-2797(97)00207-x · Cited by 278
Age at Natural Menopause and Total Mortality and Mortality from Ischemic Heart Disease
Jacobsen, B. K., Knutsen, S. F., & Fraser, G. E. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00170-x · Cited by 251
Kalantaridou, S., Davis, S. R., & Nelson, L. M. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70051-7 · Cited by 205
Self-citationEndogenous Estrogen Exposure and Cardiovascular Mortality Risk in Postmenopausal Women
de Kleijn, M. J. J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.339 · Cited by 201
Virdis, A., Ghiadoni, L., Pinto, S., Lombardo, M., Petraglia, F., Gennazzani, A., Buralli, S., Taddei, S., & Salvetti, A. (2000) · Circulation · doi:10.1161/01.cir.101.19.2258 · Cited by 173
Nelson, L. M., Anasti, J. N., Kimzey, L. M., Defensor, R., Lipetz, K. J., White, B. J., Shawker, T. H., & Merino, M. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962345 · Cited by 172
Bone Loss in Young Women With Karyotypically Normal Spontaneous Premature Ovarian Failure
Anasti, J. N. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00583-8 · Cited by 147
Koh, K. K., Jin, D., Yang, S. H., Lee, S.-K., Hwang, H. Y., Kang, M. H., Kim, W. S., Kim, D. S., Choi, I. S., & Shin, E. K. (2001) · Circulation · doi:10.1161/01.cir.103.15.1961 · Cited by 142
Estrogen Replacement and Brachial Artery Flow-Mediated Vasodilation in Older Women
Herrington, D. M., Espeland, M. A., Crouse, J. R., Robertson, J., Riley, W. A., McBurnie, M. A., & Burke, G. L. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.100241 · Cited by 141
Estrogen Replacement Reverses Endothelial Dysfunction in Postmenopausal Women
Bush, D. E., Jones, C. E., Bass, K. M., Walters, G. K., Bruza, J. M., & Ouyang, P. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00117-x · Cited by 122
Kim, T. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00077-x · Cited by 121
Endogenous Estrogen and Acetylcholine-Induced Vasodilation in Normotensive Women
Pinto, S., Virdis, A., Ghiadoni, L., Bernini, G., Lombardo, M., Petraglia, F., Genazzani, A. R., Taddei, S., & Salvetti, A. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.268 · Cited by 106
Kaplan, J. R., Adams, M. R., Anthony, M. S., Morgan, T. M., Manuck, S. B., & Clarkson, T. B. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2094 · Cited by 76
Hormone replacement therapy and endothelial function
de Kleijn, M. J. J., Wilmink, H. W., Bots, M. L., Bak, A. A. A., van der Schouw, Y. T., Planellas, J., Engelen, S., Banga, J.-D., & Grobbee, D. E. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00507-x · Cited by 65
Ohta, H., Sugimoto, I., Masuda, A., Komukai, S., Suda, Y., Makita, K., Takamatsu, K., Horiguchi, F., & Nozawa, S. (1996) · Bone · doi:10.1016/8756-3282(95)00480-7 · Cited by 64
Hormone replacement therapy and coronary artery atherosclerosis: the monkey model.
Clarkson, T. B., Ms, A., & Kp, K. (1996) · PubMed · Cited by 59
Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women
Hamelin, B. A., Méthot, J., Arsenault, M., Pilote, S., Poirier, P., Planté, S., & Bogaty, P. M. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00051-2 · Cited by 55
Hormone Replacement Therapy and Endothelial Function
Vita, J. A., & Keaney, J. F. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvb.21.12.1867 · Cited by 44
Hormone Replacement Following Early Menopause
Cooper, G. S. (2002) · JAMA · doi:10.1001/jama.288.22.2824-jlt1211-2-1 · Cited by 4
Flagged first, then by citations
1 of the 45 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
ESHRE Guideline: management of women with premature ovarian insufficiency
The ESHRE Guideline Group on POI, Webber, L. J., Davies, M. C., Anderson, R. A., Bartlett, J., Braat, D. D. M., Cartwright, B., Cífková, R., Keizer‐Schrama, S. D. M., Hogervorst, E., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew027 · Cited by 1,603
Premature menopause or early menopause: Long-term health consequences
Shuster, L. T., Rhodes, D. J., Gostout, B. S., Grossardt, B. R., & Rocca, W. A. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.08.003 · Cited by 845
Long-term health consequences of premature or early menopause and considerations for management
Faubion, S. S., Kuhle, C. L., Shuster, L. T., & Rocca, W. A. (2015) · Climacteric · doi:10.3109/13697137.2015.1020484 · Cited by 566
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
Sullivan, S. D., Sarrel, P. M., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.046 · Cited by 519
Okoth, K., Chandan, J. S., Marshall, T., Thangaratinam, S., Thomas, G. N., Nirantharakumar, K., & Adderley, N. J. (2020) · BMJ · doi:10.1136/bmj.m3502 · Cited by 416
Metadata
- Authors
- Kalantaridou, S. N., Naka, K. K., Papanikolaou, E., Kazakos, N., Kravariti, M., Calis, K. A., Paraskevaidis, E. A., Sideris, D. A., Tsatsoulis, A., Chrousos, G. P., & Michalis, L. K.
- Affiliations
- University of Ioannina (GR)
- University Hospital of Ioannina (GR)
- National Institutes of Health (US)
- Corresponding author
- Kalantaridou, Sophia N.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-08
- Volume
- 89
- Issue
- 8
- Pages
- 3907-3913
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2104874274
- Cited by
- 284
- References
- 45
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 19 · 2023: 19 · 2022: 16 · 2021: 20 · 2020: 20 · 2019: 18 · 2018: 10 · 2017: 17 · 2016: 19 · 2015: 7 · 2014: 11 · 2013: 3 · 2012: 14
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- premature ovarian failure, endothelial dysfunction, hormone therapy, estrogen replacement therapy, flow-mediated dilation, endothelium-dependent vasodilation, nitroglycerin, premature menopause, sex hormone deficiency, cardiovascular risk, young women
- MeSH terms
- Adult, Brachial Artery, Constriction, Endothelium, Vascular, Female, Nitroglycerin, Hand, Humans, Hyperemia, Regional Blood Flow, Ultrasonography, Vasodilation, Vasodilator Agents, Cohort Studies, Estrogen Replacement Therapy, Primary Ovarian Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review